>PROKKA_00001 hypothetical protein
VVAAVLGIASIGPIANINAVVDIIANIFPTLPDISENVPFILAQAIIPVNGKPTPVIKKP
IIAAGA*
>PROKKA_00002 isoaspartyl dipeptidase
MTMTDKKHVNDCILINNGKIEKIAKKIEINNESIEVIDAKGGWVMPGIIDAHCHIGIMEE
GIKFEGMDLNEYSSAITPHLRAIDGINPRDLAFQSAIEAGITTVMTGMGSSNPIGGQFAI
IKTYGKSVDEMVVKAPAALKIAFGENPKSIFGKKGSMPITRMGTAALIRETLYKAKNYMN
RKEEALKEGKIFDIDIKMESIIPVLKKEIPLKAHAHRSDDILTAIRIAKEFDLKLTIDHG
TEAHLVADYIKESGFPVIAGPNMNFRGKVETKNRSYNTTKILQEKEILYAMITDHPVVPI
EFLPMSAALAVKNGLKEEDALKAITINPAKILGIDDRVGTLDVGKEADICIYNDNPLNMN
SKNMYTIISGNIVYDFNKNL*
>PROKKA_00003 hypothetical protein
MHFCRKCGNKLQENSKRCNTCGSELEKIHKEEISSIRDKEKLLDNEIFNDEHILEHKEEP
LEIIRKFNLIKKIKENKVFLIAILILIIIVTPLIKNPIKNFVIRKNPANWLVYAADKCKK
SDTLDTVSDFKIKSTVESQEFMNYKDIENIIEQCTLRVNNKINKKTNERYSKVSLIYKEE
NILNGEIYSNKEYMAISMPQLYKDIMYIKWEDVNKLINNNNENKNISETIDPKNYENVLN
IKKSKYYDNVNGDYREFFNKIMDDYVQRGDKVDIVTKQEDKEKTIKCDEIVVHLDNERII
KILNAFFQKVSKDENLKLLVRDKVFEFFSTVQKNQDLNKFNLSKEDADNIKRDFDSEYDS
FMKELSHVEKIDKKASNGKINSLTKVKIDSKNYIRGVQSEISIDKKKTSFNFISNTVINS
IDSKLDIKKISKEGAKDISKFTAKDREDIAIEMENNIQKIMFSKLNIK*
>PROKKA_00004 hypothetical protein
MESTQIMSFSREELIKQLIKETKLISAKGVQETLKDIFTNIFKGMLEAKLDNHLGYSDLI
LPRDIEGSFDLQVMKKNRNHILIVFDKFI*
>PROKKA_00005 Botulinum neurotoxin type B precursor
MPVTINNFNYNDPIDNDNIIMMEPPFARGTGRYYKAFKITDRIWIIPERYTFGYKPEDFN
KSSGIFYRDVCEYYDPDYLNTNDKKNIFLQTMIKLFNRIKSKPLGEKLLEMIINGIPYLG
DRRVPLEEFNTNIASVTVNKLISNPGEVERKKGIFANLIIFGPGPVLNENETIDIGIQNH
FASREGFGGIMQMKFCPEYVSVFNNVQENKGASIFNRRGYFSDPALILMHELIHVLHGLY
GIKVDDLPIVPNEKKFFMQSTDAIQAEELYTFGGQDPRIITPSTDKSIYDKVLQNFRGIV
DRLNKVLVCISDPNININIYKNKFKDKYKFVEDSEGKYSIDVESFDKLYKSLMFGFTETN
IAENYKIKTRASYFSDSLPPVKIKNLLDNEIYTIEEGFNISDKNMEKEYRGQNKAINKQA
YEEISKEHLAVYKIQMCKSVRAPGICIDVDNEDLFFIADKNSFSDDLSKNERIEYDTQSN
YIENRSSIDELILDTNLISKIELPSENTESLTDFNVDVPVYEKQPAIKKIFTDENTIFQY
LYSQTFPLDIRDISLTSSFDDALLFSNKVYSFFSMDYIKTANKVVEAGLFAGWVKQIVDD
FVIEANKSSTMDKIADISLIVPYIGLALNVGNETAKGNFENAFEIAGASILLEFIPELLI
PVVGAFLLESYIDNKNKIIKTIDNALTKRDEKWIDMYGLIVAQWLSTVNTQFYTIKEGMY
KALNYQAQALEEIIKYKYNIYSEKEKSNINIDFNDINSKLNEGINQAIDNINNFINECSV
SYLMKKMIPLAVEKLLDFDNTLKKNLLNYIDENKLYLIGSAEYEKSKVDKHLKTIIPFDL
SMYTNNTILIEIFNKYNSEILNNIILNLRYRDNNLIDLSGYGAKVEVYNGVELNDKNQFK
LTSSANSKIRVTQNQDIIFNSMFLDFSVSFWIRIPKYKNDGIQNYIHNEYTIINCIKNNS
GWKISIRGNKIIWTLTDINGKTKSVFFEYSIRKDVSEYINRWFFVTITNNSDNAKIYING
KLESNIDIKDIGEVIANGEIIFKLDGDIDRTQFIWMKYFSIFNTELSQSNIKEIYKIQSY
SEYLKDFWGNPLMYNKEYYMFNAGNKNSYIKLKKDSSVGEILTRSKYNQNSNYINYRNLY
IGEKFIIRRKSNSQSINDDIVRKEDYIYLDFFNLNQEWRVYAYKDFKKKEEKLFLANIYD
SNEFYNTIQIKEYDEQPTYSCQLLFKKDEESTDEIGLIGIHRFYESGIVFKDYKDYFCIS
KWYLKEVKRKPYNPNLGCNWQFIPKDEGWIE*
>PROKKA_00006 Botulinum neurotoxin type A precursor
MCVEINLGEWLDMNINDNLSINSPVDNKNVVVVRARKTDTFFKAFKVAPNIWVAPERYYG
ESLSIDEEYKVDGGIYDSNFLSQDSEKDKFLQAIITLLKRINSTNAGEKLLSLISTAIPF
PYGYIGGGYYAPNMITFGSAPKSNKKLNSLISSTIPFPYAGYRETNYLSSEDNKSFYASN
IVIFGPGANIVENNTVFYKKEDAENGMGTMTEIWFQPFLTYKYDQFYIDPAIELMKCLIK
SLYFLYGIKPSDDLVVPYRLRNELENIEYSQLNIVDLLVSGGIDPKFINTDPYWFIDNYF
SNAKKMFEDHRNIYETEIEGNNAIGNDIKLRLKQKFRININDIWELNLNYFSKEFNIMMP
DRFNNALKHFYRKQYYKIDYPENYSINGFVNGQINAQLSLSDRNQDIINKPEEIINLLNE
NNVLLMRSNIYGDGLKSTVDDFYSNYKIPYNRAYEYHFNNSNDSSLDNVNIGVIDNIPEI
IDVNPYKENCDKFSPVQKITSTREINTNIPWPINYLQAQNTNNEKFSLSSDFVEVVSSKD
KSLVYSFLSNVMFYLDSIKDNSPIDTDKKYYLWLREIFKNYSFDITATQEINTNCGINKV
VTWFGKALNILNTSDSFVEEFQNLGPISLINKKENLSMPIIEIYEIPNDMLGLPLNDLNE
KLFNIYLKNILYFKKVYFNFLDQWWTEYYSQYFDLICMAKQSILAQEKLIKQIIQNKLQD
LSKADISMDKLNLMNLATEKTFIDLSNESQIAINNINDFLNKSAICVFDTNIYPKFISFM
EQCINSVNSNVTAFIQKCTNITEDEKLQLIKLNTFMNIDFEFFDIQSIKDLITSETDLIK
EEKESDYNLFLFTLQEDNNKVIEDISGKNTLVKYSDSISLVYGVNGDALYLKEPDESVSF
SNKAFENGLTNSFSICFWLRNLGEDIITSKLIENKADNCGWEIYFQNNGLVFSIVDCNGN
EENIYLSDVISKNWYYISISIDRLRNQLLIFINDKLIANQSIEQILNIYSSNTISLVNGN
NPIYVEGLSILNRSITSEEVVNNYFSYLNNSYIRDISGERLEYNKTYELYNYVFPENSLY
EVTENNNIYLSIKDTNNLNIQGAKFKLINIDTNKQYVQKWDEGVVCLLGDEEKYVDISSE
NNRIQLVSSKDTAKRIIFNNDIFRPNCLTFAYNNKYLSLSFRDRNYNWMICNNNDNIPKA
AHLWALKGI*
>PROKKA_00007 transcriptional regulator BotR, P-21
MNKLFLQIKMLKNNNREFQEIFKHFEKTINIFTRKYNIYDNYNDILYHLWYTLKKVDLSN
FNTQNDLERYISRTLKRYCLDICNKRKIDKKIIYNSEIVDKKLSLIANSYSSYLEFEFND
LISILPDDQKKIIYMKFVEDIKEIDIAKKLNISRQSVYKNKILALERLEPILKKLINM*
>PROKKA_00008 hypothetical protein
MEHHSVIQNSLNDKIVTISCKADTDLFFYQAIGKVSLFQQTRNYFERWRLIYDSNKAAYK
IKSMDIHNTNLVLTWNAPTHNISAQQDSNADNQYWLLLKDIGNNSFIIASYKNPNLVLYA
DTVARNLKLSTLNNSSYIKFIIEDYVISDFKNFTCRISPILAGGKVVQQVSMTNLDVNLY
IWNNSPNQKWTIIYNEEKAAYQFFNKILSDGVLTWIFSNGNTVRVSSSAQNNDAQYWLIN
PVSDNYDRYTITNLLDKTKVLDLYGGQTADGTAIQVFNSNGGNNQIWTMNDL*
>PROKKA_00009 HA 17 kDa subunit
MSVERTFLPNGNYNIKSIFSDSLYLNPVSGSLTFSNESSANDQKWNVEYMAKNRCFKISN
VAEPNKYLSYDNFGFISLDSLSNRCYWFPIKIAVNTYIMLSLNKVNELDYAWDIYDTNKN
ILSQPLLLLPNFDIYNSNEMFKLEKI*
>PROKKA_00010 Hemagglutinin components HA-22/23/53 precursor
MNSSIKKIYNDIQEKVINYSDTIDLADGNYVVSRGDGWILSRQNQILGGSVISNGSTGIV
GDLRVNDNAIPYYYPTPSFNEEYIKNNIQTVFANFTEANQIPIGFEFSKTAPSNKNLYMY
LQYTYIRYEIIKVLQHEIIERAVLYVPSLGYVKSIEFNPGEKINKDFYFLTNDKCILNEQ
FLYKQILETTKNIPTNNIFNSKVSSTQRVLPYSNGLYVINKGDGYIRTNDKDLIGTLLIE
AGSSGSIIQPRLRNTTRPLFTTSNDTKFSQQYTEERLKDAFNVQLFNTSTSLFKFVEEAP
SDKNICIKAYNTYEKYELIDYQNGSIVNKAEYYLPSLGYCEVTNAPSPESEVVKTQVPED
GFIQNGPEEEIVVGVIDPSENIQEINTAISDNYTYNIPGIVNNNPFYILFTVNTTGIYKI
NAQNNLPPLKIYEAIGSGNRNFQSGNLCDDDIKAINYITGFDSPNAKSYLVVLLNKDKNY
YIRVPQTSSNIENQIKFEREEGDLRNLMNSSVNIIDDLNSTGAHYYTRQSPDVGNYISYE
FTVPGNFNNKDTSNIRLYTSNNQGIGTLFRVTETIDGYNLINIQQNLNLLNSTKSIRLLN
GAIYILKVEVTELNNYNIRLHIDITN*
>PROKKA_00011 hypothetical protein
MGTRLKELSLIYKNNTLNEDDKKNIEYEAKSLLDNMYFTIKNTKFNGKNLFTGEKLNIQG
STYNTDIKLMDFKVPKEDSIFIGNNKSSNESHTIKISDTEIDVILKKYNLEKANKIIFYE
SEMVDKHNIKTVFTSKYGYKNNANIDIVNVSNNVNKMFSINGTINDNSEVKGYLQEEDNK
LIGNININDKEYNIQLETTMEYALKTNLNSIKTTIINKNNHTFRGNTSIVDIQDNSGMTY
TSKEITIYEFKEIIANNKSNNKNKQIVFELSNNKKITFDINNKDINLYIFDEEYNSFDIS
DILNSSNIIEEKVLSELNNYQNYIGIKTNELEYKLNFEQNNQIL*
>PROKKA_00012 hypothetical protein
MKLSTNKKVNIAADSPSEIERINRINTSVRSRNIAVRIFKKEYLYYK*
>PROKKA_00013 hypothetical protein
MKIKHTKVNEYYNYLKESFANVNLSEEHRMDIYKKIEIIEALVSLYEQKYEFDDEIIEDL
KLKYRPVFPEELKNIQKNLEKTIIK*
>PROKKA_00014 hypothetical protein
MGKRGEVLKVNKITIVGEFMHFKISYIIATKLVYNRKC*
>PROKKA_00015 hypothetical protein
MSMDIPEYLIETIFENIDQRLKQNFYNFYENLFNMNNKEENLKLLIKDIIQREFIVAELT
KISDMDLHKTKHTFIAPNKVNKLKRYNLQQIKQTKKDGIIHYLKRKKQIH*
>PROKKA_00016 hypothetical protein
LKYSLDNSIFVTNFFYLKSETNKQINITFNLHFIYNICTIISDKWNNNLNFIYMEYPRLL
LDHSLVADGSEKVKVQKQTIIQQNHSNKDVKYKYNDYVPKDRIARILVPESNIDTKQSRL
IYNKDLNILSNILKYKKADFLTNKTIIFNLIDIINNIYCSKIIRSYEDLRNRIAKMTLLK
FNFFRTDNTSGIPDAVYGIFSSYEYLDKSQNKVKVYVDSILYDKILKNQVSTIYNDKINQ
FEISDLFSNKNTSDILPVI*
>PROKKA_00017 hypothetical protein
MHDKNIHNYCNNKYKKIIKKYKIYNNINIDKTYIQFSLTQIKQMLVYYYANSKGFVSLIS
KKRIARMIGCCEKNIDINNKLFLDLGLILISSTINNKFSLIIKNYSEHYSKNNTRYLNLA
TNVLRT*
>PROKKA_00018 hypothetical protein
MKTFLPDYINCKSAIEKVINKLNRNTITMLFNNSEKLIFVISKNLHGKLLKKEMYYKYKN
NFLNYITENNIKLNNLSYSINNIIKLAFEYGYDIIQLILGEIKAIAPTIFNVGRYI*
